Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02761694
Title ARQ 751 as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ArQule

Advanced Solid Tumor

Her2-receptor negative breast cancer

triple-receptor negative breast cancer


ARQ 751 + Paclitaxel

ARQ 751

ARQ 751 + Fulvestrant

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST